You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACAD Exercise Disclosure
Thompson Elizabeth H.Z. · SEC Form 4 · Filed Jul 31, 2026
Exercise
Calculated transaction value
$0
Thompson Elizabeth H.Z. EVP, Head Of Research & Dev
ACAD
Transaction date
Jul 29, 2026
Public filing date
Jul 31, 2026
Filing lag
Filed 2 days later
ACAD daily price context
Close on/before transaction
$26.34
Jul 29, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 32,272 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001861477-26-000005
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$432.66K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acadia Pharmaceuticals Inc ACAD | Sale | Jul 30, 2026 | $431.35K |
| Acadia Pharmaceuticals Inc ACAD | Sale | Jul 30, 2026 | $1.31K |
| Acadia Pharmaceuticals Inc ACAD | Exercise | Jul 29, 2026 | Not reported |
| Acadia Pharmaceuticals Inc ACAD Current | Exercise | Jul 29, 2026 | $0 |